Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, placebo-controlled, parallel-group comparative study.
Diabetes Obes Metab
; 20(2): 453-457, 2018 02.
Article
in En
| MEDLINE
| ID: mdl-28786530
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Diabetes Mellitus, Type 2
/
Membrane Transport Modulators
/
Thiazolidines
/
Dipeptidyl-Peptidase IV Inhibitors
/
Canagliflozin
/
Hyperglycemia
Type of study:
Clinical_trials
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Diabetes Obes Metab
Journal subject:
ENDOCRINOLOGIA
/
METABOLISMO
Year:
2018
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom